Cerus reported $79.28M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Atrion ATRI:US 19.27M 5.93M
Cerulean Pharma CERU:US $ 16.4M 0.34M
Cerus CERS:US $ 79.28M 12.62M
Cytori Therapeutics CYTX:US $ 6.97M 2.05M
Haemonetics HAE:US $ 180.49M 261.78M
Meridian Bioscience VIVO:US $ 60.35M 3.88M
Nuvasive NUVA:US $ 701.36M 452.63M
Orasure Technologies OSUR:US $ 65.49M 9.9M
Quidel QDEL:US $ 900M 407.34M
Sientra SIEN:US $ 84.39M 0.26M
Staar Surgical STAA:US $ 46.51M 5.33M
Terumo 4543:JP Y 183465M 5744M
Utah Medical Products UTMD:US $ 4.44M 576K